Crown Bioscience, Inc. (taicang)

Binchen Mao

Sheng Guo

Henry Qixiang Li

Dawei Chen

A panel of gene expression markers for gastric cancer patient treated or to be treated by cetuximab is provided. Methods and compositions are also provided, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to predict a gastric cancer patient's response to cetuximab.

System and method for determining Cetuximab sensitivity on gastric cancer

Provided in the disclosure relates to a panel of gene expression markers for cancer patient treated or to be treated by karenitecin. The disclosure provides methods and compositions, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to predict a cancer patient's response to karenitecin. Such information can be used in determining prognosis and treatment options for cancer patients.

Growing community of inventors

Jiangsu, China

Binchen Mao